Cargando…

Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates

PURPOSE: Calcineurin inhibitor (CNI) use has improved lung transplantation outcomes. However, significant perioperative complications in patients receiving CNI can deteriorate the early course of lung transplantation. To date, there is no consensus regarding the optimal agent for the induction regim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ha Eun, Paik, Hyo Chae, Jeong, Su Jin, Park, Moo Suk, Kim, Song Yee, Lee, Jin Gu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859690/ https://www.ncbi.nlm.nih.gov/pubmed/33527796 http://dx.doi.org/10.3349/ymj.2021.62.2.164

Ejemplares similares

Preoperative Corticosteroid Use and Early Postoperative Bronchial Anastomotic Complications after Lung Transplantation
por: Kim, Ha Eun, et al.
Publicado: (2018)

The Assessment and Outcomes of Crossmatching in Lung Transplantation in Korean Patients
por: Kim, Ha Eun, et al.
Publicado: (2022)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
por: Gundlapalli, S., et al.
Publicado: (2013)

Risk factors and mortality of acute kidney injury within 1 month after lung transplantation
por: Kim, Nam Eun, et al.
Publicado: (2021)

Critical Care before Lung Transplantation
por: Lee, Jin Gu, et al.
Publicado: (2018)

Critical Care after Lung Transplantation
por: Kim, Song Yee, et al.
Publicado: (2018)

Impact of extended-criteria donor lungs according to preoperative recipient status and age in lung transplantation
por: Suh, Jee Won, et al.
Publicado: (2020)

Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
por: Kim, Hyung Duk, et al.
Publicado: (2023)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)

Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
por: Park, Ji Eun, et al.
Publicado: (2018)

Risk factors for neuromuscular complications in lower limbs after lung transplantation
por: Cho, Soomi, et al.
Publicado: (2022)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
por: Salis, Paola, et al.
Publicado: (2008)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
por: Lee, Jun Young, et al.
Publicado: (2022)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

The Prediction and Prognosis of Fungal Infection in Lung Transplant Recipients—A Retrospective Cohort Study in South Korea
por: Baek, Yae-Jee, et al.
Publicado: (2021)

Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
por: Koch, Martina, et al.
Publicado: (2009)

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
por: Ansari, David, et al.
Publicado: (2015)

Incidental Lung Cancer of Explanted Lungs from Lung Transplant Recipients: Incidence, Characteristics, and 5-Year Survival
por: Choi, Yong Jun, et al.
Publicado: (2020)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Extracorporeal Membrane Oxygenation Bridge to Lung Transplantation in a Patient with Hermansky-Pudlak Syndrome and Progressive Pulmonary Fibrosis
por: Sim, Wooho, et al.
Publicado: (2019)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

Anastomotic Airway Complications after Lung Transplantation
por: Cho, Eun Na, et al.
Publicado: (2015)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
por: Ajlan, Aziza, et al.
Publicado: (2021)

Aspergillus Galactomannan Titer as a Diagnostic Marker of Invasive Pulmonary Aspergillosis in Lung Transplant Recipients: A Single-Center Retrospective Cohort Study
por: Kim, Eun-Young, et al.
Publicado: (2023)

Factors Associated with Lung Function Recovery at the First Year after Lung Transplantation
por: Yoon, Bo Ra, et al.
Publicado: (2018)

Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
por: Kim, Sang Jin, et al.
Publicado: (2020)

Comparison of Predicted Total Lung Capacity and Total Lung Capacity by Computed Tomography in Lung Transplantation Candidates
por: Hwang, Sung Ho, et al.
Publicado: (2016)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Feasibility of Immediate in-Intensive Care Unit Pulmonary Rehabilitation after Lung Transplantation: A Single Center Experience
por: Song, Joo Han, et al.
Publicado: (2018)

Long- and short-term clinical impact of awake extracorporeal membrane oxygenation as bridging therapy for lung transplantation
por: Kim, Nam Eun, et al.
Publicado: (2021)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report
por: Ijiri, Naohiro, et al.
Publicado: (2022)

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Role of Klotho in Chronic Calcineurin Inhibitor Nephropathy
por: Luo, Kang, et al.
Publicado: (2019)

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
por: Zhao, Ke, et al.
Publicado: (2022)

Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction
por: Weissenbacher, Annemarie, et al.
Publicado: (2015)

A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation
por: Nickerson, Peter W., et al.
Publicado: (2020)

Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients
por: Masset, Christophe, et al.
Publicado: (2023)

Clinical significance of postoperative atrial arrhythmias in patients who underwent lung transplantation
por: Kim, Byung Gyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ae3ufsipt52ada0eflot5ds2p7